An Immunoprofiling Workshop – sponsored by the Cornell Center for Immunology, Dec. 13 in Stocking Hall – will feature technology experts who will provide case studies and best practices on various core technologies.
Researchers at Weill Cornell Medicine and NewYork-Presbyterian have discovered a function of the protein adipsin that could help inform new treatments for type 2 diabetes.
A protein that breast, lung and other cancers use to promote their spread – or metastasis – to the brain, has been identified by a team led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
Professors Holly Prigerson and Valerie Reyna have combined forces to study end-of-life communication between patients and their physicians and clinicians, with the goal of improved prognostic understanding and decision-making and, ultimately, better end-of-life decisions.
A team of Cornell researchers and scientists focused on pain management has received a five-year, $3 million grant from the National Institute on Aging, part of the National Institutes of Health.
A high-salt diet may impair cognitive function by causing a deficiency of nitric oxide, which is vital for maintaining vascular health in the brain, according to a new study from Weill Cornell Medicine.
Powerful lab and computational techniques developed by scientists at Weill Cornell Medicine and two other centers will enable scientists to map tumors’ ability to develop resistance to drugs.
New cellular and molecular processes underlying communication between gut microbes and brain cells have been described for the first time by scientists at Weill Cornell Medicine and Cornell’s Ithaca campus.
